作者
Chong Wang,Xinjie Qiu,Xinyue Zeng,Shaobang Wu,Meixian Liu,Xiuyun Ren
摘要
ABSTRACT Oral wound healing is notoriously difficult in diabetes. Hyperglycemia upregulates GLUT1, driving excessive glucose influx and compounding local dysbiosis, which together fuel oxidative damage and persistent inflammation. Current topical therapies lack both mucosal retention and etiology-directed design, failing to reverse this underlying metabolic disruption. To address these challenges, we developed AA2G@Q4F-FG, an injectable, thermosensitive, and glucose-responsive hydrogel, designed not only to provide rapid hemostasis and antibacterial activity through quaternized chitosan against oral pathogens, but also to fundamentally combat glucose overload via GLUT1-targeted substrate competition. Ascorbic acid 2-glucoside (AA2G) was validated as a functional GLUT1-engaging substrate via molecular docking, SPR binding kinetics, competitive 2-NBDG uptake, and feedback downregulation of GLUT1 at the transcriptional/protein level. When loaded in this mucoadhesive matrix with glucose-triggered release, AA2G enables sustained, on-demand competition at the wound interface. In vitro, the hydrogel scavenged ROS, promoted macrophage polarization toward an M2-like state, and restored fibroblast/epithelial/endothelial cell functions. In vivo, it accelerated closure, increased collagen deposition and angiogenesis, and remodeled the pathological milieu. Transcriptomic profiling revealed that the hydrogel broadly reprogrammed the wound microenvironment across metabolic, inflammatory, and repair signaling networks. Notably, the hydrogel unexpectedly induced endogenous FGF1, activated AKT/ERK signaling, and modulated the Hippo/YAP1 pathway, with YAP1 redistribution to the cytoplasm, consistent with restored cellular homeostasis. Taken together, this glucose-competitive dressing targets the metabolic root of delayed oral healing: AA2G engages GLUT1 as a rapidly reversible competitive substrate to curb glucose influx, and the hydrogel modulates FGF1-dependent AKT/ERK–Hippo/YAP1 signaling associated with restored tissue homeostasis and repair.